Author

Arcan Güven

Observed name: Arcan Guven

Institution: BPGbio, Inc. (United States)

Observed institutions: Pennsylvania State University, Constructor University, Berg (United States), BPGbio, Inc. (United States), Universitat Rovira i Virgili, RWTH Aachen University

ORCID: 0000-0002-3407-3609

Observed ORCID: 0000-0002-3407-3609

OpenAlex ID: A5039399228

Functionalized Nanocompartments (Synthosomes) with a Reduction‐Triggered Release System

2008 · Ozana Onaca, Pransenjit Sarkar, et al. · Angewandte Chemie International Edition · 64

The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer

2022 · Nicole E. Pellegrino, Arcan Guven, et al. · International Journal of Molecular Sciences · 59

PDF

Rapid and efficient method for the size separation of homogeneous fluorescein-encapsulating liposomes

2009 · Arcan Güven, Mayreli Ortiz, et al. · Journal of Liposome Research · 37

Power Harvesting from Human Serum in Buckypaper-Based Enzymatic Biofuel Cell

2016 · Güray Güven, Samet Şahin, et al. · Frontiers in Energy Research · 29

PDF

Molecular understanding of sterically controlled compound release through an engineered channel protein (FhuA)

2010 · Arcan Güven, Marco Fioroni, et al. · Journal of Nanobiotechnology · 23

PDF

Residue K556‐A Light Triggerable Gatekeeper to Sterically Control Translocation in FhuA

2011 · Arcan Güven, Tamara Dworeck, et al. · Advanced Engineering Materials · 19

Power Generation from Human Leukocytes/Lymphocytes in Mammalian Biofuel Cell

2013 · Güray Güven, Pablo Lozano-Sanchez, et al. · International Journal of Electrochemistry · 16

PDF

Identification and validation of N-acetylputrescine in combination with non-canonical clinical features as a Parkinson’s disease biomarker panel

2024 · Kuan-Wei Peng, Allison Klotz, et al. · Scientific Reports · 13

Functionalized Nanocompartments (Synthosomes) with a Reduction‐Triggered Release System

2008 · Ozana Onaca, Pransenjit Sarkar, et al. · Angewandte Chemie · 8

Diablo ubiquitination analysis by sandwich immunoassay

2019 · Arcan Guven, Wenfang S. Wu, et al. · Journal of Pharmaceutical and Biomedical Analysis · 6

Multiplexed LC-MS/MS analysis of methylsuccinic acid, ethylmalonic acid, and glutaric acid in plasma and urine

2022 · Kuan-Wei Peng, Allison Klotz, et al. · Analytical Biochemistry · 4

Development and validation of an immunoassay for quantification of NCAM-1 in human plasma

2021 · Arcan Guven, Kayleigh Gray, et al. · Journal of Pharmaceutical and Biomedical Analysis · 3

Abstract 1663: Development of a novel oral microtubule targeting agent with pan-cancer efficacy

2023 · Maria-Dorothea Nastke, Jacob Matson, et al. · Cancer Research · 1

Abstract 5321: BRG399: A novel potent small molecule modulator of UBE2K for the treatment of various cancers

2022 · Maria-Dorothea Nastke, Marisa Permatteo, et al. · Cancer Research · 1

Abstract 5320: BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancer

2022 · Shiva Kazerounian, Mollie O'Hara, et al. · Cancer Research · 1

Functionalized Nanocontainers Operated as Controlled Release Systems and Bioactuators

2013 · Arcan Guven · Biosensors Journal · 1

Abstract 2943: Interrogative Biology® platform identifies a novel target in the ubiquitin pathway and its utility in cancer is supported by small molecule modulators

2020 · Stephane Gesta, Shefali Sharma, et al. · Cancer Research

Works count: 17

Citation count: 282

H-index: 8

I10-index: 8